Report overview
Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
This report aims to provide a comprehensive presentation of the global market for Cancer Stem Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Stem Cell. This report contains market size and forecasts of Cancer Stem Cell in global, including the following market information:
Global Cancer Stem Cell Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Stem Cell market was valued at US$ 1086.9 million in 2022 and is projected to reach US$ 1777.9 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
We surveyed the Cancer Stem Cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Stem Cell Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Stem Cell Market Segment Percentages, by Type, 2022 (%)
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Global Cancer Stem Cell Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Stem Cell Market Segment Percentages, by Application, 2022 (%)
Stem Cell Based Cancer Therapy
Targeted CSCs
Global Cancer Stem Cell Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Stem Cell Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Stem Cell revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Stem Cell revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Stem Cell, market overview.
Chapter 2: Global Cancer Stem Cell market size in revenue.
Chapter 3: Detailed analysis of Cancer Stem Cell company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Stem Cell in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
